Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AMIGF
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -89.90 -2.06 20.41
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 34.40 -30.10 -45.89
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 5.82 3.24 3.06
Cash -58.32 4.44 10.64
Capex 34.97 -0.10 -0.15
Free Cash Flow 39.23 1.01 0.73
Revenue 13.92 6.83 6.00
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 1.67 1.00 0.98
Operating Margin -18.14 0.11 0.14
ROA 8.37 0.03 0.03
ROE -12.39 0.16 0.19
ROIC 8.41 0.09 0.08
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AMIGF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AMIGF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AMIGF is permitted for members.